People with Parkinson’s and related forms of dementia improved in a small study when they took a leukemia drug called nilotinib. Researchers say the drug seems to help brain cells eliminate toxins.
People with Parkinson’s and related forms of dementia improved in a small study when they took a leukemia drug called nilotinib. Researchers say the drug seems to help brain cells eliminate toxins.